SCHEMBL8738538

SCHEMBL8738538

CCC(C)(C)Cn1c(-c2ccc(Cl)cc2)n[nH]c1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APOBEC3G Q9HC16 4/20 0.51
GFER P55789 2/20 0.51
LMNA P02545 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
CA9 Q16790 2/20 0.44
ALDH1A1 P00352 4/20 0.42
HPGD P15428 3/20 0.42
MAPT P10636 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
KDM4E B2RXH2 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HTT P42858 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PKM P14618 1/20 0.38
KMT2A Q03164 3/20 0.37
RECQL P46063 1/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
IKBKB O14920 1/20 0.36
MAP3K14 Q99558 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8227328 0.87 APOBEC3G (0.51) APOBEC3GGFERLMNATDP1CA9
SCHEMBL8233155 0.83 APOBEC3G (0.68) APOBEC3GGFERLMNATDP1CA9
SCHEMBL8235502 0.83 APOBEC3G (0.47) APOBEC3GGFERLMNATDP1CA9
SCHEMBL8232792 0.82 APOBEC3G (0.48) APOBEC3GGFERLMNATDP1CA9
SCHEMBL16542299 0.81 APOBEC3G (0.45) APOBEC3GGFERLMNATDP1CA9
SCHEMBL165618 0.77 APOBEC3G (0.44) APOBEC3GGFERLMNATDP1CA9
SCHEMBL8233143 0.77 ALDH1A1 (0.58) APOBEC3GGFERLMNATDP1CA9
Water SCHEMBL2512796 0.76 APOBEC3G (0.43) APOBEC3GGFERLMNATDP1CA9
SCHEMBL19265137 0.74 AVPR2 (0.48) APOBEC3GGFERLMNATDP1CA9
SCHEMBL4270680 0.74 APOBEC3G (0.61) APOBEC3GGFERLMNATDP1CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2027096-B1 SUBSTITUTED ARYLIMIDAZ0L0NE AND TRIAZ0L0NE AS INHIBITORS OF VASOPRESSIN RECEPTORS Bayer Pharma AG (DE) 2012-05-23 EP disclosed